The Organising Committee of the 20th European Congress of Trauma & Emergency Surgery invites you to exhibit at the Congress in Prague, Czech Republic.
For delegates, the Congress is an opportunity to learn about, discuss and evaluate new and existing resources available in the field of Trauma and Emergency Surgery.
Early reservations ensure availability of prominent spots at this prestigious international event. An Exhibition and Sponsorship brochure is available giving detailed information on the possibilities to exhibit and sponsor various congress items that will greatly promote your company’s image.
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. We meet patients’ needs using the latest technologies to develop and deliver innovative therapies. The company offers the broadest range of products in the industry for treating coagulation disorders, primary immune deficiencies, hereditary angioedema, inherited respiratory disease, and neurological disorders. CSL Behring’s products are also used in cardiac surgery, organ transplantation, burn treatment and to prevent hemolytic disease of the newborn. The company operates one of the world’s largest plasma collection networks, CSL Plasma. The parent company, CSL Limited (ASX:CSL; USOTC:CSLLY), headquartered in Melbourne, Australia, employs more than 22,000 people, and delivers its life-saving therapies to people in more than 60 countries. For more information visit at CSLBehring.com/Vita and follow us on Twitter.com/CSLBehring.